Dr. Smith discussed the assessment of bulbar function in ALS clinical trials at Biogen Pharmaceuticals (Boston), at the ALS Investigator Research Workshop sponsored by ALSA (Philadelphia), and again in Clearwater, Florida at the NEALS annual meeting.
top of page
News
Avanir Pharmaceuticals reported that Nuedexta, a drug discovered at CNS, showed positive clinical results in treating agitation for patients with Alzheimer's disease. For more information, click here.
On June 5, 2014, the Essey Award in Los Angeles was presented to Drs. Smith, Cleveland, and Bennett for their work on the development of antisense therapeutics as a potential treatment for Amyothropic Lateral Sclerosis. This award was given by the Golden West Chapter for the ALS Association. The link to the film produced by Patrick McMinn can be accessed here, and for more information, click here.
bottom of page